Compare DRTS & ZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DRTS | ZTR |
|---|---|---|
| Founded | 2015 | N/A |
| Country | Israel | United States |
| Employees | 125 | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 546.5M | 357.2M |
| IPO Year | N/A | 1995 |
| Metric | DRTS | ZTR |
|---|---|---|
| Price | $7.25 | $6.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | ★ 269.7K | 228.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,055.39 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.30 | $5.22 |
| 52 Week High | $8.60 | $7.11 |
| Indicator | DRTS | ZTR |
|---|---|---|
| Relative Strength Index (RSI) | 52.24 | 51.91 |
| Support Level | $6.51 | $6.71 |
| Resistance Level | $7.77 | $7.11 |
| Average True Range (ATR) | 0.52 | 0.08 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 41.74 | 31.09 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.